Project Description:
Genentech, the founder of the biotechnology industry, is a company with a quarter-century track record of delivering on the promise of biotechnology. Today, Genentech is among the world's leading biotech companies, with 13 protein-based products on the market for serious or life-threatening medical conditions and 20 projects in the pipeline. With its strength in all areas of the drug development process - from research and development to manufacturing and commercialization - Genentech continues to transform the possibilities of biotechnology into improved realities for patients.

Transdyn delivered the panel design, PLC programming, and RSView programming for the system that tests experiments involving blood clot prevention.